Real-time PCR complements immunohistochemistry in the determination of HER-2/neu status in breast cancer

BACKGROUND: The clinical benefit of determining the status of HER-2/neu amplification in breast cancer patients is well accepted. Although immunohistochemistry (IHC) is the most frequently used method to assess the over-expression of HER-2 protein, fluorescent in-situ hybridization (FISH) is recogni...

Descripción completa

Detalles Bibliográficos
Autores principales: Nistor, Andreea, Watson, Peter H, Pettigrew, Norman, Tabiti, Karim, Dawson, Angelika, Myal, Yvonne
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1382241/
https://www.ncbi.nlm.nih.gov/pubmed/16420697
http://dx.doi.org/10.1186/1472-6890-6-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1382241/
https://www.ncbi.nlm.nih.gov/pubmed/16420697
http://dx.doi.org/10.1186/1472-6890-6-2

Ejemplares similares